Curvebeam Ai
- Short interest
- 0.00%
- −0.06 pp 30d
- as of 1 June 2026
- Reported shorts
- 2K
- Shares on issue
- 477.734M
Curvebeam Ai (CVB) Short Interest
Curvebeam Ai (ASX:CVB) had 0.00% of shares reported as short positions as of 1 June 2026, representing 1,987 shares. Curvebeam Ai operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Curvebeam Ai
CurveBeam AI develops and manufactures specialized medical imaging scanners and software, focusing on point-of-care diagnostic cone beam CT imaging solutions. The company combines its imaging technology with artificial intelligence (AI) and deep learning AI (DLAI) expertise to deliver solutions across orthopedics and bone health, specifically targeting fragility fracture prevention.
Company profile →Curvebeam Ai (ASX:CVB) has 0.00% of its shares on issue reported as short positions as of 1 June 2026, or about 1,987 shares. Over the past 30 days that figure has fallen 0.06 percentage points, and over 90 days it has fallen 0.14 percentage points. Its highest recorded short interest was 0.40% in August 2024. CVB is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads CVB today
- Zanger BreakoutWatchScore 10rank 1637 of 1942
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 14rank 1170 of 1716
- Crowded-Short BreakoutWatchScore 15rank 609 of 1500
- Quality compoundersNot a candidate
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
CVB fundamentals
In the year to 30 Jun 2026, Curvebeam Ai (ASX:CVB) recorded revenue of A$8.7M and a net loss after tax of A$18.8M. A year earlier it recorded revenue of A$12.1M and a net loss after tax of A$16.8M. Year-on-year growth: revenue −28.4% (FY). Net margin −217.3% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest CVB news
All news- Intellivision Holdings Voting Stake in CurveBeam AI Drops to 14.99% Following October 2026 Share Dilution
kalkine · 13 Oct 2026
- Arun and Susmita Singh's Voting Power in CurveBeam AI Limited Drops to 16.81% Following Multiple Dilution Events
kalkine · 13 Oct 2026
- CurveBeam AI (ASX:CVB) Wins China Approval and Opens the Door to 2027 Revenue - Stocks Down Under
googlenews · 12 Oct 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss CVB
Start a research thread or post the first pulse update